Alglucosidase Alfa
Alglucosidase Alfa treats Pompe disease. Ask your doctor about the Pompe Registry.
Alglucosidase Alfa Overview
Alglucosidase alfa is a prescription medication used to treat patients with Pompe disease.
Alglucosidase alfa belongs to a group of drugs called a lysosomal glycogen-specific enzyme. These work by replacing the deficient GAA, which is seen in Pompe disease, thereby reducing the accumulated glycogen in heart and skeletal muscle cells.
This medication is available in an injectable form to be given directly into a vein (IV) by a healthcare professional.
Common side effects of alglucosidase alfa include infusion-related reactions and severe allergic reactions.
How was your experience with Alglucosidase Alfa?
Uses of Alglucosidase Alfa
Alglucosidase alfa is a prescription medication used to treat patients with Pompe disease.
This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.
Alglucosidase Alfa Brand Names
Alglucosidase Alfa Drug Class
Alglucosidase Alfa is part of the drug class:
Side Effects of Alglucosidase Alfa
Serious side effects have been reported with alglucosidase alfa. See the “Alglucosidase Alfa Precautions” section.
Common side effects of alglucosidase alfa include the following:
- infusion-related reactions
- severe allergic reactions
- hives
- diarrhea
- vomiting
- shortness of breath
- itchy skin
- skin rash
- redness of skin
- neck pain
- partial hearing loss
- flushing/feeling hot
- pain in extremities
- chest discomfort
- pneumonia
- respiratory failure
- respiratory distress
- respiratory syncytial virus infection
- gastroenteritis
- fever
- sore throat
This is not a complete list of alglucosidase alfa side effects. Ask your doctor or pharmacist for more information.
Tell your doctor if you have any side effect that bothers you or that does not go away.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Alglucosidase Alfa FDA Warning
WARNING: ANAPHYLAXIS
Life-threatening anaphylactic reactions, severe allergic reactions and immune mediated reactions have been observed in some patients during alglucosidase alfa infusions. Therefore, appropriate medical support should be readily available when alglucosidase alfa is administered.
Warning: CARDIORESPIRATORY FAILURE for Myozyme (alglucosidase alfa):
Risk of Cardiorespiratory Failure patients with compromised cardiac or respiratory function may be at risk of serious acute exacerbation of their cardiac or respiratory compromise due to infusion reactions, and require additional monitoring.